Home›People›Steve Zaniboni
SZ

Steve Zaniboni

Chief Financial Officer at selectIon.

ExecutivePublic company
Updated Nov 9, 2026·Latest SEC filing Sep 15, 2025·Suggest an edit

About Steve Zaniboni

Steve Zaniboni is a chief financial officer at selectIon.

Steve Zaniboni reports to the SEC as a director, officer or major shareholder of 2 public companies: Cardiff Oncology (CRDF) and Sorrento Therapeutics (SRNEQ).

Steve Zaniboni first appears on SEC filings in 2009.

Experience

This experience comes from SEC filings. The years are when the filings name Steve Zaniboni in the role, so the role may have started earlier or lasted longer.

selectIon, Inc.
Chief Financial Officer
2019 – 2025 · San Diego, CA
Cardiff Oncology, Inc.
Former CFO and director
2012 – 2016 · Public company (CRDF)
Sorrento Therapeutics, Inc.
Director and 10% owner
2009 – 2010 · Public company (SRNEQ)

Key Colleagues at Startups

The people Steve Zaniboni works with at each company, as listed on that company's latest Form D.

selectIon, Inc. · Form D, Sep 15, 2025
CG
MF
AS
Antonius Schuh
Executive officer and director
DS
Don Scifres
Director
MW
Mark Wiggins
Director

Sources

  1. SECselectIon, Inc. Form D, filed Sep 15, 2025
  2. SECForms 3, 4 and 5 filed by Steve Zaniboni (SEC filer 1234887)